BKS Advisors’s Idexx Laboratories IDXX Stock Holding History

BKS Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$705K	Hold	3,154	–	–	0.28%	85
2018 Q4	$587K	Hold	3,154	–	–	0.27%	92
2018 Q3	$787K	Hold	3,154	–	–	0.29%	88
2018 Q2	$687K	Hold	3,154	–	–	0.24%	102
2018 Q1	$604K	Hold	3,154	–	–	0.22%	110
2017 Q4	$493K	Hold	3,154	–	–	0.18%	129
2017 Q3	$490K	Hold	3,154	–	–	0.19%	122
2017 Q2	$509K	Hold	3,154	–	–	0.21%	117
2017 Q1	$488K	Hold	3,154	–	–	0.21%	118
2016 Q4	$370K	Hold	3,154	–	–	0.17%	126
2016 Q3	$356K	Hold	3,154	–	–	0.16%	115
2016 Q2	$293K	Hold	3,154	–	–	0.15%	132
2016 Q1	$247K	Hold	3,154	–	–	0.13%	145
2015 Q4	$230K	Hold	3,154	–	–	0.12%	140
2015 Q3	$234K	Hold	3,154	–	–	0.13%	123
2015 Q2	$202K	Hold	3,154	–	–	0.1%	151
2015 Q1	$244K	Buy	+3,154	New	+$245K	0.12%	126

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BKS Advisors's IDXX Position: Q1 2019 in Review

BKS Advisors held its Idexx Laboratories (IDXX) position steady in Q1 2019 at 3,154 shares worth $705K. The position accounts for 0.28% of the portfolio, ranked #85.

BKS Advisors first reported a position in IDXX in Q1 2015 and has held it in 17 quarters since. The position peaked at $787K in Q3 2018. 684 funds tracked by Wall St. Rank hold IDXX as of Q1 2019.

BKS Advisors held 3,154 shares of Idexx Laboratories worth $705K as of Q1 2019.
BKS Advisors left its Idexx Laboratories share count unchanged in Q1 2019.
Idexx Laboratories made up 0.28% of BKS Advisors's portfolio in Q1 2019, its #85 holding.
BKS Advisors first reported a position in Idexx Laboratories in Q1 2015 and has held it in 17 quarters since.
BKS Advisors's Idexx Laboratories position peaked at $787K in Q3 2018.
684 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.